Lupin Appoints Brian Savage as President and Chief Legal Officer
Lupin Ltd 路 Change in Management 路 23 Oct 2026, 4:00 am
Lupin Appoints Brian Savage as President and Chief Legal Officer Lupin Limited has appointed Brian Savage as Senior Management Personnel, designated as President and Chief Legal Officer, effective 22nd Oct'26. In this full-time role, Savage will lead the company's global legal, compliance, and intellectual property (IP) functions. He brings extensive global pharmaceutical experience, having previously served as Executive Vice President and Interim Global Chief Legal Officer at Teva Pharmaceuticals, as well as practicing law at Dechert LLP.
Original exchange filing (PDF)
More announcements from Lupin Ltd
- Lupin Announces European Launch of Biosimilar Ranibizumab. 路 12 Nov 2026
- Transcript of Q2 FY2027 Earnings Conference Call. 路 07 Nov 2026
- Link of Audio recording of the Earnings Call-Q2 FY27. 路 05 Nov 2026
- Investor Presentation- Q2 FY2027 路 04 Nov 2026
- Lupin Q2 FY2027 Results 路 04 Nov 2026
- Appointment of Mr. Akhil Gupta as an Additional Director (Non-Executive, Independent) effective November 03, 2026 and as an Independent Director for a term of five consecutive years with .... 路 04 Nov 2026
- Unaudited Standalone and Consolidated Financial Results for the quarter and half year ended September 30, 2026. 路 04 Nov 2026
- Unaudited Standalone and Consolidated Financial Results for the quarter and half year ended September 30, 2026. 路 04 Nov 2026
